Tci Wealth Advisors, Inc. Rigel Pharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.67 - $3.19 $1,132 - $5,391	-1,690 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$2.22 - $3.45 $3,751 - $5,830	1,690 New	1,690 $5,000
Q4 2021 Jan 24, 2022	SELL	$2.36 - $3.57 $1,656 - $2,506	-702 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$3.5 - $4.5 $546 - $702	156 Added 28.57%	702 $3,000
Q2 2021 Aug 02, 2021	BUY	$3.09 - $4.54 $194 - $286	63 Added 13.04%	546 $2,000
Q1 2021 Apr 29, 2021	BUY	$3.35 - $4.93 $1,618 - $2,381	483 New	483 $2,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.